Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Lower testosterone levels increase kidney stone risk in men over 40.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The risks of testosterone implants in women outweigh the benefits.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A new method accurately measures long-term steroid levels in human hair.

Hirsute women have higher testosterone, cholesterol, and glucose levels.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Testosterone levels influence male behaviors and physical traits, but this relationship is complex and influenced by both internal and external factors.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Different hair loss patterns may be linked to varying male hormone levels.

Men with androgenetic alopecia may have more severe dry eye and meibomian gland dysfunction.

Older men with lower levels of available testosterone are more likely to be frail.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Thiol/disulfide balance is normal in male AGA patients but shifts towards oxidative stress with emotional stress and low vitamin D.